Aprogen Pharmaceuticals Inc (003060) — Cash Flow-to-Debt Ratio
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of ₩-7.66 Billion could theoretically repay 0% of its total liabilities (₩288.27 Billion) in one year. Explore 003060 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aprogen Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for Aprogen Pharmaceuticals Inc across 13 annual periods. Also explore 003060 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Aprogen Pharmaceuticals Inc (2010–2024)
Year-by-year debt coverage analysis for Aprogen Pharmaceuticals Inc. For market capitalisation and broader financial context, see Aprogen Pharmaceuticals Inc (003060) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.15x | ₩-31.00 Billion | ₩212.29 Billion | ▲ +4.2% |
| 2023 | -0.15x | ₩-33.65 Billion | ₩220.71 Billion | ▼ -203.0% |
| 2022 | 0.15x | ₩25.73 Billion | ₩173.73 Billion | ▲ +141.5% |
| 2021 | -0.36x | ₩-6.23 Billion | ₩17.44 Billion | ▼ -174.8% |
| 2020 | 0.48x | ₩8.09 Billion | ₩16.95 Billion | ▲ +1079.5% |
| 2019 | 0.04x | ₩713.73 Million | ₩17.65 Billion | ▲ +102.2% |
| 2018 | 0.02x | ₩1.33 Billion | ₩66.55 Billion | ▲ +118.0% |
| 2017 | -0.11x | ₩-8.93 Billion | ₩80.41 Billion | ▼ -1347.7% |
| 2016 | 0.01x | ₩449.98 Million | ₩50.57 Billion | ▼ -91.6% |
| 2015 | 0.11x | ₩1.85 Billion | ₩17.48 Billion | ▲ +134.7% |
| 2014 | -0.30x | ₩-6.92 Billion | ₩22.71 Billion | ▼ -288.5% |
| 2013 | -0.08x | ₩-1.70 Billion | ₩21.71 Billion | ▼ -1234.7% |
| 2010 | 0.01x | ₩247.92 Million | ₩35.89 Billion | — |